{"abstract": "The recent actions of Zoetis and Allergan suggest a more subdued approach to deals.", "web_url": "https://www.nytimes.com/2016/05/11/business/dealbook/change-is-in-the-air-for-pharmaceutical-mergers.html", "snippet": "The recent actions of Zoetis and Allergan suggest a more subdued approach to deals.", "lead_paragraph": "The pharmaceuticals merger mind-set may be changing. Allergan, the $87 billion maker of Botox, will devote capital to stock buybacks and paying down debt.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Change Is in the Air for Pharmaceutical Mergers", "kicker": "Breakingviews", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "organizations", "value": "ALLERGAN INC", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Zoetis Inc", "rank": 3, "major": "N"}, {"name": "persons", "value": "Ackman, William A", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 5, "major": "N"}], "pub_date": "2016-05-10T23:01:50+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By Robert Cyran", "person": [{"firstname": "Robert", "middlename": null, "lastname": "Cyran", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/cc677553-4c1d-5703-b5df-7df222697f8a", "word_count": 386, "uri": "nyt://article/cc677553-4c1d-5703-b5df-7df222697f8a"}